Loading...
Improved survival and MRD remission with blinatumomab vs. chemotherapy in children with first high-risk relapse B-ALL
Locatelli, F. Zugmaier, G. Rizzari, C. Morris, J. D. Gruhn, B. Klingebiel, T. Parasole, R. Linderkamp, C. Flotho, C. Petit, A.
Locatelli, F.
Zugmaier, G.
Rizzari, C.
Morris, J. D.
Gruhn, B.
Klingebiel, T.
Parasole, R.
Linderkamp, C.
Flotho, C.
Petit, A.
Citations
Altmetric:
Abstract
None
Description
Date
2022
Publisher
Collections
Files
Keywords
Type
Article
Citation
Locatelli F, Zugmaier G, Rizzari C, Morris JD, Gruhn B, Klingebiel T, et al. Improved survival and MRD remission with blinatumomab vs. chemotherapy in children with first high-risk relapse B-ALL. Leukemia. 2022 Dec 8. PubMed PMID: 36482128. Epub 2022/12/10. eng.